Daytrana — Class II drug recall D-1172-2017
Terminated recall by Noven Pharmaceuticals, Inc., reported 2017-09-27, distributed nationwide. Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.
| Recall number | D-1172-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Noven Pharmaceuticals, Inc., Miami, FL, United States |
| Recall initiated | 2017-08-30 |
| Classified | 2017-09-18 |
| Reported by FDA | 2017-09-27 |
| Terminated | 2020-01-24 |
| Distributed | Nationwide (US) |
| Quantity | 234,960 patches |
| NDC | 68968-5552, 68968-5552-03, 68968-5553, 68968-5553-03, 68968-5554, 68968-5554-03, 68968-5555, 68968-5555-03 |
| Lot numbers | 10/17, 80426 |
Product
Daytrana (methylphenidate transdermal system) Delivers 15 mg over 9 hours (1.6 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5553-3
Reason for recall
Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1172-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.